The Current Ratio as of December 2024 (TTM) for Bright Minds Biosciences Inc. (DRUG) is 35.08

According to Bright Minds Biosciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 35.08. This represents a change of 87.01% compared to the average of 18.76 of the last 4 quarters.

Bright Minds Biosciences Inc. (DRUG) Historical Current Ratio (quarterly & annually)

How has DRUG Current Ratio performed in the past?

The mean historical Current Ratio of Bright Minds Biosciences Inc. over the last ten years is 14.35. The current 35.08 Current Ratio has changed 24.34% with respect to the historical average. Over the past ten years (40 quarters), DRUG's Current Ratio was at its highest in in the June 2021 quarter at 68.80. The Current Ratio was at its lowest in in the December 2019 quarter at 0.

Bright Minds Biosciences Inc. (DRUG) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bright Minds Biosciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bright Minds Biosciences Inc. (DRUG) Average Current Ratio

How has DRUG Current Ratio performed in the past?

The current Current Ratio of Bright Minds Biosciences Inc. (DRUG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bright Minds Biosciences Inc. (DRUG) Current Ratio vs. Peers

How is DRUG’s Current Ratio compared to its peers?

Bright Minds Biosciences Inc.’s Current Ratio is greater than Revelation Biosciences, Inc. (1.64), greater than Zura Bio Limited (10.36), greater than Phio Pharmaceuticals Corp. (6.38), greater than ZyVersa Therapeutics, Inc. (33.83), greater than TransCode Therapeutics, Inc. (1.58), greater than Pyxis Oncology, Inc. (7.33), greater than eFFECTOR Therapeutics, Inc. (1.03), greater than Altamira Therapeutics Ltd. (1.38), greater than Elevation Oncology, Inc. (17.77), greater than Apexigen, Inc. (1.29), greater than Immix Biopharma, Inc. (3.47), greater than Virios Therapeutics, Inc. (7.27), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Aditxt, Inc. (0.09), greater than NeuroBo Pharmaceuticals, Inc. (2.41), greater than Dermata Therapeutics, Inc. (3.44), greater than Unicycive Therapeutics, Inc. (3.61),

Build a custom stock screener for Bright Minds Biosciences Inc. (DRUG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bright Minds Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bright Minds Biosciences Inc. (DRUG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bright Minds Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.